Document is current

Any future updates will be listed below

Formononetin as a potential therapeutic agent for asthma: evidence from in vivo and in vitro models of attenuated inflammation via cAMP/PKA pathway inhibition

Crossref DOI link: https://doi.org/10.1007/s11626-026-01160-4

Published Online: 2026-02-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark